As the closely watched screening test moves closer to Food and Drug Administration approval, MedTech Dive asked cancer ...
With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the Type 2 population.
Edwards is asking customers to return some of the delivery systems used with its Sapien M3 devices after receiving three ...
MiniMed completed its separation from Medtronic, the companies said Thursday. The diabetes technology firm, which went public ...
The American Medical Association has released a new governance framework to ensure the safe and effective use of AI agents in healthcare. The framework is based on the principle that for agentic AI ...
Chief commercial officer, EndoQuest Robotics. Previous title: Vice president of robotics, AI and neuroscience, HCA Healthcare ...
The results come as Dexcom is awaiting a decision from the Centers for Medicare and Medicaid Services to expand Medicare ...
Labcorp will pick up specialty testing in women’s health as well as a blood test that assesses the likelihood of finding aggressive prostate cancer before a biopsy decision.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results